首页 | 本学科首页   官方微博 | 高级检索  
   检索      


HtrA1 Is a Novel Antagonist Controlling Fibroblast Growth Factor (FGF) Signaling via Cleavage of FGF8
Authors:Goo-Young Kim  Ho-Young Kim  Hyun-Taek Kim  Jeong-Mi Moon  Cheol-Hee Kim  Seongman Kang  Hyangshuk Rhim
Institution:aDepartment of Medical Life Sciences;bDepartment of Biomedical Sciences, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea;cDepartment of Biology, Chungnam National University, Daejeon, Republic of Korea;dGraduate School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea
Abstract:Accumulating evidence suggests that HtrA1 (high-temperature requirement A1) is involved in modulating crucial cellular processes and implicated in life-threatening diseases, such as cancer and neuropathological disorders; however, the exact functions of this protease in vivo remain unknown. Here, we show that loss of HtrA1 function increases fibroblast growth factor 8 (FGF8) mRNA levels and triggers activation of FGF signaling, resulting in dorsalization in zebrafish embryos. Notably, HtrA1 directly cleaves FGF8 in the extracellular region, and this cleavage results in decreased activation of FGF signaling, which is essential for many physiological processes. Therefore, HtrA1 is indispensable for dorsoventral patterning in early zebrafish embryogenesis and serves as a key upstream regulator of FGF signaling through the control of FGF levels. Furthermore, this study offers insight into new strategies to control human diseases associated with HtrA1 and FGF signaling.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号